206 related articles for article (PubMed ID: 34780847)
1. TNF inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2).
Deuitch NT; Yang D; Lee PY; Yu X; Moura NS; Schnappauf O; Ombrello AK; Stone D; Kuehn HS; Rosenzweig SD; Hoffmann P; Cudrici C; Levy DM; Kessler E; Soep JB; Hay AD; Dalrymple A; Zhang Y; Sun L; Zhang Q; Tang X; Wu Y; Rao K; Li H; Luo H; Zhang Y; Burnham JM; Boehm M; Barron K; Kastner DL; Aksentijevich I; Zhou Q
J Allergy Clin Immunol; 2022 May; 149(5):1812-1816.e6. PubMed ID: 34780847
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2.
Carmona-Rivera C; Khaznadar SS; Shwin KW; Irizarry-Caro JA; O'Neil LJ; Liu Y; Jacobson KA; Ombrello AK; Stone DL; Tsai WL; Kastner DL; Aksentijevich I; Kaplan MJ; Grayson PC
Blood; 2019 Jul; 134(4):395-406. PubMed ID: 31015188
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral Mediated
Hong Y; Casimir M; Houghton BC; Zhang F; Jensen B; Omoyinmi E; Torrance R; Papadopoulou C; Cummins M; Roderick M; Thrasher AJ; Brogan PA; Eleftheriou D
Front Immunol; 2022; 13():852830. PubMed ID: 35529868
[TBL] [Abstract][Full Text] [Related]
4. Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation.
Nihira H; Izawa K; Ito M; Umebayashi H; Okano T; Kajikawa S; Nanishi E; Keino D; Murakami K; Isa-Nishitani M; Shiba T; Honda Y; Hijikata A; Yasu T; Kubota T; Hasegawa Y; Kawashima Y; Nakano N; Takada H; Ohga S; Heike T; Takita J; Ohara O; Takei S; Takahashi M; Kanegane H; Morio T; Iwaki-Egawa S; Sasahara Y; Nishikomori R; Yasumi T
J Allergy Clin Immunol; 2021 Aug; 148(2):550-562. PubMed ID: 33529688
[TBL] [Abstract][Full Text] [Related]
5. Adenosine Deaminase 2 Deficiency (DADA2): A Crosstalk Between Innate and Adaptive Immunity.
Signa S; Bertoni A; Penco F; Caorsi R; Cafaro A; Cangemi G; Volpi S; Gattorno M; Schena F
Front Immunol; 2022; 13():935957. PubMed ID: 35898506
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
Meyts I; Aksentijevich I
J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
[TBL] [Abstract][Full Text] [Related]
7. [Multiple facets of ADA2 deficiency: Vasculitis, auto-inflammatory disease and immunodeficiency: A literature review of 135 cases from literature].
Fayand A; Sarrabay G; Belot A; Hentgen V; Kone-Paut I; Grateau G; Melki I; Georgin-Lavialle S
Rev Med Interne; 2018 Apr; 39(4):297-306. PubMed ID: 29273180
[TBL] [Abstract][Full Text] [Related]
8. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2).
Cooray S; Omyinmi E; Hong Y; Papadopoulou C; Harper L; Al-Abadi E; Goel R; Dubey S; Wood M; Jolles S; Berg S; Ekelund M; Armon K; Eleftheriou D; Brogan PA
Rheumatology (Oxford); 2021 Sep; 60(9):4373-4378. PubMed ID: 33420503
[TBL] [Abstract][Full Text] [Related]
10. Analysis of deficiency of adenosine deaminase 2 pathogenesis based on single-cell RNA sequencing of monocytes.
Watanabe N; Gao S; Wu Z; Batchu S; Kajigaya S; Diamond C; Alemu L; Raffo DQ; Hoffmann P; Stone D; Ombrello AK; Young NS
J Leukoc Biol; 2021 Sep; 110(3):409-424. PubMed ID: 33988272
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency.
Yap JY; Moens L; Lin MW; Kane A; Kelleher A; Toong C; Wu KHC; Sewell WA; Phan TG; Hollway GE; Enthoven K; Gray PE; Casas-Martin J; Wouters C; De Somer L; Hershfield M; Bucciol G; Delafontaine S; Ma CS; Tangye SG; Meyts I
J Clin Immunol; 2021 Nov; 41(8):1915-1935. PubMed ID: 34657246
[TBL] [Abstract][Full Text] [Related]
12. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
Lee PY; Kellner ES; Huang Y; Furutani E; Huang Z; Bainter W; Alosaimi MF; Stafstrom K; Platt CD; Stauber T; Raz S; Tirosh I; Weiss A; Jordan MB; Krupski C; Eleftheriou D; Brogan P; Sobh A; Baz Z; Lefranc G; Irani C; Kilic SS; El-Owaidy R; Lokeshwar MR; Pimpale P; Khubchandani R; Chambers EP; Chou J; Geha RS; Nigrovic PA; Zhou Q
J Allergy Clin Immunol; 2020 Jun; 145(6):1664-1672.e10. PubMed ID: 31945408
[TBL] [Abstract][Full Text] [Related]
13. Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2.
Chen L; Mamutova A; Kozlova A; Latysheva E; Evgeny F; Latysheva T; Savostyanov K; Pushkov A; Zhanin I; Raykina E; Kurnikova M; Mersiyanova I; Platt CD; Jee H; Brodeur K; Du Y; Liu M; Weiss A; Schulert GS; Rodriguez-Smith J; Hershfield MS; Aksentijevich I; Zhou Q; Nigrovic PA; Shcherbina A; Alexeeva E; Lee PY
J Allergy Clin Immunol; 2023 Sep; 152(3):771-782. PubMed ID: 37150360
[TBL] [Abstract][Full Text] [Related]
14. Early onset is an indication of the severity of DADA2 disease.
Zhao X; Zhang J; Li C; Kuang W; Deng J; Tan X; Li C; Li S; Wang J
Rheumatology (Oxford); 2023 Feb; 62(2):969-976. PubMed ID: 35471231
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2).
Lee PY; Aksentijevich I; Zhou Q
Semin Immunopathol; 2022 May; 44(3):269-280. PubMed ID: 35178658
[TBL] [Abstract][Full Text] [Related]
16. Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency.
Barzaghi F; Cicalese MP; Zoccolillo M; Brigida I; Barcella M; Merelli I; Sartirana C; Zanussi M; Calbi V; Bernardo ME; Tucci F; Migliavacca M; Giglio F; Doglio M; Canarutto D; Ferrua F; Consiglieri G; Prunotto G; Saettini F; Bonanomi S; Rovere-Querini P; Di Colo G; Jofra T; Fousteri G; Penco F; Gattorno M; Hershfield MS; Bongiovanni L; Ponzoni M; Marktel S; Milani R; Peccatori J; Ciceri F; Mortellaro A; Aiuti A
Front Immunol; 2022; 13():910021. PubMed ID: 36248833
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of adenosine deaminase 2 (DADA2): Review.
Sharma V; Deo P; Sharma A
Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101844. PubMed ID: 37328410
[TBL] [Abstract][Full Text] [Related]
18. A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience.
Rama M; Duflos C; Melki I; Bessis D; Bonhomme A; Martin H; Doummar D; Valence S; Rodriguez D; Carme E; Genevieve D; Heimdal K; Insalaco A; Franck N; Queyrel-Moranne V; Tieulie N; London J; Uettwiller F; Georgin-Lavialle S; Belot A; Koné-Paut I; Hentgen V; Boursier G; Touitou I; Sarrabay G
Eur J Hum Genet; 2018 Jul; 26(7):960-971. PubMed ID: 29681619
[TBL] [Abstract][Full Text] [Related]
19. Human adenosine deaminase 2 deficiency: A multi-faceted inborn error of immunity.
Moens L; Hershfield M; Arts K; Aksentijevich I; Meyts I
Immunol Rev; 2019 Jan; 287(1):62-72. PubMed ID: 30565235
[TBL] [Abstract][Full Text] [Related]
20. A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2).
Melo A; de Carvalho LM; Ferriani VPL; Cavalcanti A; Appenzeller S; Oliveira VR; Neto HC; Rosário NA; de Oliveira Poswar F; Guimaraes MX; Kokron CM; Maia RE; Silva GD; Keller G; Ferreira MD; Vasconcelos DM; Toledo-Barros MAM; Barros SF; Neto NSR; Krieger MH; Kalil J; Mendonça LO
Adv Rheumatol; 2023 May; 63(1):23. PubMed ID: 37217999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
